This report should not be construed as providing investment advice. It is for educational purposes only. Before making any investment decision, you should always do your own research or consult a investment professional.
While I try to be accurate, I assume no responsibility for any figure in this spreadsheet. Estimates Estimates Estimates
See my website on stocks or see my blog at the following sites. www.spbrunner.com/stocks.html www.spbrunner.blogspot.com/ Q3 2016
Johnson and Johnson NYSE: JNJ-N www.jnj.com/ Fiscal Yr: Dec 31
Year 12/31/04 12/31/05 12/31/06 12/31/07 12/31/08 12/31/09 12/31/10 12/31/11 12/31/12 12/31/13 12/31/14 12/31/15 12/31/16 12/31/17 12/31/18 Value Description #Y Item
Reporting Date 12/28/14 1/3/15
Accounting Rules US GAAP IFRS IFRS IFRS IFRS IFRS IFRS IFRS
USD - CDN$ 1.2048 1.1630 1.1652 0.9881 1.2240 1.0501 0.9970 1.0213 0.9968 1.0636 1.1601 1.3847 1.3519 1.3519 1.3519 1.76% <-IRR #YR-> 10 USD - CDN$ 1.38% To Date
-6.78% -3.47% 0.19% -15.20% 23.87% -14.21% -5.06% 2.44% -2.40% 6.70% 9.07% 19.36% -2.37% 0.00% 6.79% <-IRR #YR-> 5 USD - CDN$ 5.99% 2015
$71,595 <-12 mths 2.17%
Sales* $47,348 $50,514 $53,324 $61,095 $63,747 $61,897 $61,587 $65,030 $67,224 $71,312 $74,331 $70,074 $72,080 $75,592 $78,247 38.72% <-Total Growth 10 Revenue US$
Increase 13.10% 6.69% 5.56% 14.57% 4.34% -2.90% -0.50% 5.59% 3.37% 6.08% 4.23% -5.73% 2.86% 4.87% 3.51% 3.33% <-IRR #YR-> 10 Revenue US$
5 year Running Average $37,492 $41,805 $45,869 $50,829 $55,206 $58,115 $60,330 $62,671 $63,897 $65,410 $67,897 $69,594 $71,004 $72,678 $74,065 2.62% <-IRR #YR-> 5 Revenue US$
Revenue per Share $15.95 $16.19 $18.39 $21.35 $22.98 $22.43 $22.49 $23.87 $24.19 $25.28 $26.71 $25.43 $26.16 $27.44 $28.40 5.23% <-IRR #YR-> 10 5 yr Running Average US$
Increase 13.12% 1.49% 13.59% 16.08% 7.62% -2.36% 0.27% 6.13% 1.35% 4.50% 5.63% -4.77% 2.86% 4.87% 3.51% 2.90% <-IRR #YR-> 5 5 yr Running Average US$
5 year Running Average $12.69 $13.85 $15.37 $17.20 $18.97 $20.27 $21.53 $22.62 $23.19 $23.66 $24.51 $25.10 $25.56 $26.20 $26.83 4.62% <-IRR #YR-> 10 Revenue per Share US$
P/S (Price/Sales) Med 3.56 4.00 3.44 3.01 2.76 2.49 2.74 2.63 2.78 3.28 3.66 3.88 4.23 0.00 0.00 2.49% <-IRR #YR-> 5 Revenue per Share US$
P/S (Price/Sales) 3.98 3.71 3.59 3.12 2.61 2.87 2.75 2.75 2.90 3.62 3.92 4.04 4.39 4.19 4.46 6.13% <-IRR #YR-> 10 5 yr Running Average US$
*Sales to Customers in M US $ P/S Med 10 yr 2.90 5 yr 3.28 51.64% Diff M/C 3.12% <-IRR #YR-> 5 5 yr Running Average US$
-$50,514 $0 $0 $0 $0 $0 $0 $0 $0 $0 $70,074
-$61,587 $0 $0 $0 $0 $70,074
-$41,805 $0 $0 $0 $0 $0 $0 $0 $0 $0 $69,594
-$60,330 $0 $0 $0 $0 $69,594
-$16.19 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $25.43
-$22.49 $0.00 $0.00 $0.00 $0.00 $25.43
-$13.85 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $25.10
-$21.53 $0.00 $0.00 $0.00 $0.00 $25.10
$6.59 <-12 mths 6.29%
Adjusted Earnings $12,900 $13,300 $15,471 $20,563
Adjusted Earnings $3.10 $3.39 $3.76 $4.15 $4.55 $4.63 $4.76 $5.00 $5.10 $5.52 $6.39 $6.20 $6.72 $7.15 $7.66 82.87% <-Total Growth 10 Adjusted EPS US$
Increase 14.8% 9.4% 10.9% 10.4% 9.6% 1.8% 2.8% 5.0% 2.0% 8.2% 15.8% -3.0% 8.4% 6.4% 7.1% 6.22% <-IRR #YR-> 10 Earnings US$
5 year Running Average $3.04 $3.42 $3.79 $4.10 $4.37 $4.62 $4.81 $5.00 $5.35 $5.64 $5.99 $6.40 $6.82 5.43% <-IRR #YR-> 5 Earnings US$
Earnings Yield 4.9% 5.6% 5.7% 6.2% 7.6% 7.2% 7.7% 7.6% 7.3% 6.0% 6.1% 6.0% 5.8% 6.2% 6.1% 5.85% <-IRR #YR-> 7 5 yr Running Average US$
P/E on Close 20.46 17.73 17.57 16.07 13.16 13.91 13.01 13.12 13.75 16.59 16.36 16.57 17.10 16.07 16.52 5.24% <-IRR #YR-> 5 5 yr Running Average US$
P/E on High 20.73 20.47 18.27 16.48 15.76 14.03 13.87 13.58 14.22 17.26 17.07 17.16 16.12 <-Median-> 5 P/E on High US$
P/E on Low 15.89 17.74 15.33 14.47 12.16 10.06 11.98 11.53 12.20 12.83 13.56 14.63 12.52 <-Median-> 5 P/E on Low US$
P/E on Med 18.31 19.11 16.80 15.48 13.96 12.05 12.93 12.56 13.21 15.04 15.31 15.90 14.50 <-Median-> 5 P/E on Med US$
Payout Ratio 35.3% 37.6% 38.7% 39.0% 39.5% 41.7% 44.3% 45.0% 47.1% 46.9% 43.2% 47.6% 46.9% 44.8% 41.8% 43.76% <-Median-> 10 DPR Adj. EPS US$
Earnings before provision for Taxes on income. Payout 46.92% P/E: M/H/L 10 years 15.04 17.07 12.83 13.66% Diff M/C 13.66% Diff Med/Curr
$5.70 <-12 mths 4.01%
EPS Basic $2.84 $3.46 $3.73 $3.63 $4.57 $4.40 $4.78 $3.49 $3.86 $4.92 $5.80 $5.56 60.69% <-Total Growth 10 EPS Basic US$
EPS Diluted* $2.84 $3.46 $3.73 $3.63 $4.57 $4.40 $4.78 $3.49 $3.86 $4.81 $5.70 $5.48 $5.98 $6.52 $6.52 58.38% <-Total Growth 10 EPS Diluted US$
Increase 18.33% 21.83% 7.80% -2.68% 25.90% -3.72% 8.64% -26.99% 10.60% 24.61% 18.50% -3.86% 9.12% 9.03% 0.00% 4.71% <-IRR #YR-> 10 Earnings per Share US$
Earnings Yield 4.5% 5.8% 5.6% 5.4% 7.6% 6.8% 7.7% 5.3% 5.5% 5.3% 5.5% 5.3% 5.2% 5.7% 5.2% 2.77% <-IRR #YR-> 5 Earnings per Share US$
5 year Running Average $2.17 $2.54 $2.92 $3.21 $3.65 $3.96 $4.22 $4.17 $4.22 $4.27 $4.53 $4.67 $5.17 $5.70 $6.04 6.27% <-IRR #YR-> 10 5 yr Running Average US$
10 year Running Average $1.65 $1.91 $2.17 $2.42 $2.77 $3.06 $3.38 $3.55 $3.72 $3.96 $4.24 $4.45 $4.67 $4.96 $5.15 2.03% <-IRR #YR-> 5 5 yr Running Average US$
* Diluted ESP per share E/P 10 Yrs 5.48% 5Yrs 5.33%
-$3.46 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $5.48
-$4.78 $0.00 $0.00 $0.00 $0.00 $5.48
-$2.54 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.67
-$4.22 $0.00 $0.00 $0.00 $0.00 $4.67
Special Dividends $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 <-Median-> 10 Special Dividends US$
pre-split 1997 US$
pre-split 2001 US$
Dividend* $1.10 $1.28 $1.46 $1.62 $1.80 $1.93 $2.11 $2.25 $2.40 $2.59 $2.76 $2.95 $3.15 $3.20 $3.20 131.37% <-Total Growth 10 Dividends US$
Increase 18.38% 16.44% 14.12% 11.34% 10.80% 7.52% 9.33% 6.64% 6.67% 7.92% 6.56% 6.88% 6.78% 1.59% 0.00% Count 28 Years of data US$
Dividends 5 Yr Running $0.83 $0.96 $1.11 $1.27 $1.45 $1.62 $1.78 $1.94 $2.10 $2.26 $2.42 $2.59 $2.77 $2.93 $3.05 170.35% <-Total Growth 10 Dividends 5 Yr Running US$
Yield H/L Price 1.93% 1.97% 2.30% 2.52% 2.83% 3.46% 3.43% 3.58% 3.56% 3.12% 2.82% 2.99% 2.85% 3.06% <-Median-> 10 Yield H/L Price US$
Yield on High Price 1.70% 1.84% 2.12% 2.37% 2.50% 2.97% 3.20% 3.31% 3.31% 2.72% 2.53% 2.77% 2.51% 2.75% <-Median-> 10 Yield on High Price US$
Yield on Low Price 2.22% 2.12% 2.52% 2.70% 3.24% 4.14% 3.70% 3.90% 3.86% 3.66% 3.19% 3.25% 3.29% 3.45% <-Median-> 10 Yield on Low Price US$
Yield on Close Price 1.73% 2.12% 2.20% 2.43% 3.00% 3.00% 3.41% 3.43% 3.42% 2.83% 2.64% 2.87% 2.74% 2.78% 2.53% 2.93% <-Median-> 10 Yield on Close Price US$
Payout Ratio EPS 38.56% 36.85% 39.01% 44.63% 39.28% 43.86% 44.14% 64.47% 62.18% 53.85% 48.42% 53.83% 52.68% 49.08% 49.08% 46.52% <-Median-> 10 DPR EPS US$
DPR EPS 5 Yr Running 38.11% 37.72% 38.01% 39.66% 39.71% 40.80% 42.21% 46.50% 49.69% 52.86% 53.49% 55.48% 53.62% 51.42% 50.53% 44.35% <-Median-> 10 DPR EPS 5 Yr Running US$
Payout Ratio CFPS 29.19% 33.49% 29.61% 30.40% 33.26% 32.13% 35.26% 42.87% 43.31% 41.95% 41.59% 42.16% 48.17% 39.22% #DIV/0! 38.42% <-Median-> 10 DPR CF US$
DPR CF 5 Yr Running 26.77% 28.56% 29.50% 29.81% 31.21% 31.73% 32.25% 34.71% 37.21% 38.96% 40.93% 42.32% 43.43% 42.45% #DIV/0! 33.48% <-Median-> 10 DPR CF 5 Yr Running US$
Payout Ratio CFPS WC 32.00% 31.10% 31.80% 33.62% 30.31% 34.96% 33.48% 48.46% 38.40% 39.80% 39.32% 45.31% 48.17% 39.22% #DIV/0! 36.68% <-Median-> 10 DPR CF WC US$
DPR CF WC 5 Yr Running 29.26% 30.19% 30.74% 31.79% 31.70% 32.38% 32.83% 35.67% 36.61% 38.60% 39.42% 41.87% 42.19% 42.17% #DIV/0! 34.25% <-Median-> 10 DPR CF WC 5 Yr Running US$
Median Values Yield 3.12% 2.87% Payout 53.85% 42.16% 39.80% 8.75% <-IRR #YR-> 10 Dividends US$
* Dividends per share Curr diff -10.71% Last Div Inc ---> $0.75 $0.80 6.7% 6.93% <-IRR #YR-> 5 Dividends US$
-$1.28 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.95
-$2.11 $0.00 $0.00 $0.00 $0.00 $2.95
Historical Dividends Historical High Div 3.86% Low Div 1.14% Ave Div 2.50% Med Div 2.18% Close Div 1.98% Historical Dividends US$
High/Ave/Median Values Curr diff Exp. -27.86% 144.28% Cheap 11.39% Cheap 27.74% Cheap 41.00% High/Ave/Median US$
Future Dividend Yield Div Yd 3.89% earning in 5 Years at IRR of 6.90% Div Inc. 39.60% Future Dividend Yield US$
Future Dividend Yield Div Yd 5.43% earning in 10 Years at IRR of 6.90% Div Inc. 94.88% Future Dividend Yield US$
Future Dividend Yield Div Yd 7.58% earning in 15 Years at IRR of 6.90% Div Inc. 172.06% Future Dividend Yield US$
Yield if held 5 yrs 2.37% 2.96% 2.87% 3.03% 3.35% 3.40% 3.26% 3.56% 3.74% 4.08% 4.95% 4.79% 5.02% 4.75% 3.85% 3.48% <-Median-> 10 Dividends US$
Yield if held 10 yrs 9.47% 6.99% 6.09% 5.59% 4.69% 4.18% 4.90% 4.45% 4.49% 4.84% 4.86% 4.55% 4.99% 4.98% 5.04% 4.76% <-Median-> 10 Dividends US$
Yield if held 15 yrs 17.37% 16.50% 12.85% 12.74% 16.18% 16.69% 11.56% 9.41% 8.28% 6.77% 5.97% 6.86% 6.22% 5.99% 5.97% 10.49% <-Median-> 10 Dividends US$
Yield if held 20 yrs 36.94% 30.61% 27.31% 19.88% 18.87% 23.35% 23.87% 16.16% 13.18% 11.04% 8.36% 23.61% <-Median-> 8 Dividends US$
Yield if held 25 yrs 53.30% 43.77% 38.18% 27.83% 25.16% 28.85% 43.77% <-Median-> 3 Dividends US$
Yield if held 30 yrs 65.85% #NUM! <-Median-> 0 Dividends
Cost covered if held 5 years 8.95% 11.13% 10.96% 11.92% 13.52% 14.23% 13.76% 15.36% 16.32% 17.76% 21.71% 21.05% 22.06% 21.75% 18.38% 14.79% <-Median-> 10 Dividends US$
Cost covered if held 10 years 54.29% 39.63% 34.80% 32.83% 28.28% 26.42% 31.85% 30.13% 31.53% 34.57% 35.57% 33.75% 37.28% 39.13% 41.79% 32.34% <-Median-> 10 Dividends US$
Cost covered if held 15 years 117.24% 110.04% 86.26% 87.76% 114.52% 124.13% 88.45% 75.40% 69.00% 57.74% 52.63% 61.95% 57.50% 58.94% 63.06% 80.83% <-Median-> 10 Dividends US$
Cost covered if held 20 years 281.46% 245.31% 225.36% 171.99% 170.20% 216.20% 228.86% 159.41% 133.33% 119.55% 97.61% 220.78% <-Median-> 8 Dividends US$
Cost covered if held 25 years 513.58% 437.38% 392.97% 294.34% 285.38% 353.75% 437.38% <-Median-> 3 Dividends US$
Cost covered if held 30 years 827.62% #NUM! <-Median-> 0 Dividends US$
Special Dividend Cdn$ * $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 #DIV/0! <-Total Growth 10 Special Dividends CDN$
Dividend Cdn$ * $1.32 $1.48 $1.70 $1.60 $2.20 $2.03 $2.10 $2.30 $2.39 $2.75 $3.20 $4.08 $4.26 $4.33 $4.33 175.49% <-Total Growth 10 Dividends CDN$
Increase 10.35% 12.40% 14.33% -5.58% 37.26% -7.75% 3.80% 9.24% 4.11% 15.15% 16.23% 27.58% 4.25% 1.59% 0.00% 11.79% <-Median-> 10 Dividends CDN$
Yield 1.73% 2.12% 2.20% 2.43% 3.00% 3.00% 3.41% 3.43% 3.42% 2.83% 2.64% 2.87% 2.74% 2.78% 2.53% 10.66% <-IRR #YR-> 10 Dividends CDN$
Median Values 5 Yr M Yield 2.87% 14.19% <-IRR #YR-> 5 Dividends CDN$
* Dividends per share to C. DY Curr diff -3.03% Last Div Inc ---> $1.04 $1.08 4.1%
-$1.48 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.08
-$2.10 $0.00 $0.00 $0.00 $0.00 $4.08
Close Cdn$ $76.41 $69.90 $76.97 $65.91 $73.27 $67.64 $61.75 $66.98 $69.88 $97.42 $121.31 $142.24 $155.35 $155.35 $171.06 7.36% <-IRR #YR-> 10 Stock Price CDN$
5 yr Period ending 12/31/04 12/31/05 12/31/06 12/31/07 12/31/08 12/31/09 12/31/10 12/31/11 12/31/12 01/11/13 12/31/14 12/31/15 12/31/16 12/31/17 12/31/18 18.16% <-IRR #YR-> 5 Stock Price CDN$
5 year IRR 3.77% -0.97% -2.59% -2.79% 4.69% 0.06% 0.44% 0.06% 4.44% 8.66% 15.35% 21.51% 4.44% <-Median-> 17 5 year IRR CDN$
9.81% <-IRR #YR-> 10 Price & Dividend CDN$
As a Canadian, would I have made money on this stock? Looking at 5 year periods to, including Dividends D. per yr 2.44% 3.35% % Tot Ret 24.91% 15.58% 21.51% <-IRR #YR-> 5 Price & Dividend CDN$
-$69.90 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $142.24 Stock Price CDN$
-$61.75 $0.00 $0.00 $0.00 $0.00 $142.24 Stock Price CDN$
-$69.90 $1.70 $1.60 $2.20 $2.03 $2.10 $2.30 $2.39 $2.75 $3.20 $146.33 Dates Price & Div CDN$
-$61.75 $2.30 $2.39 $2.75 $3.20 $146.33
-$67.64 $2.10 $2.30 $2.39 $2.75 $124.51 12/31/14 Price & Div CDN$
-$73.27 $2.03 $2.10 $2.30 $2.39 $100.17 12/31/13 Price & Div CDN$
-$65.91 $2.20 $2.03 $2.10 $2.30 $72.27 12/31/12 Price & Div CDN$
-$76.97 $1.60 $2.20 $2.03 $2.10 $69.28 12/31/11 Price & Div CDN$
-$69.90 $1.70 $1.60 $2.20 $2.03 $63.86 12/31/10 Price & Div CDN$
-$76.41 $1.48 $1.70 $1.60 $2.20 $69.66 12/31/09 Price & Div CDN$
$1.32 $1.48 $1.70 $1.60 $75.47 12/31/08 Price & Div CDN$
$1.32 $1.48 $1.70 $67.51 12/31/07 Price & Div CDN$
$1.32 $1.48 $78.67 12/31/06 Price & Div CDN$
$1.32 $71.38 12/31/05 Price & Div CDN$
$77.73 12/31/04 Price & Div CDN$
12/31/03 Price & Div CDN$
12/31/02 Price & Div CDN$
12/31/01 Price & Div CDN$
12/31/00 Price & Div CDN$
12/31/99 Price & Div CDN$
Graham No. $26.17 $30.74 $33.74 $35.16 $39.69 $42.60 $47.14 $40.56 $45.01 $53.30 $56.69 $56.43 $59.61 $62.25 $62.25 83.54% <-Total Growth 10 Graham Number US$
Price/GP Ratio Med 2.17 2.11 1.87 1.83 1.60 1.31 1.31 1.55 1.50 1.56 1.73 1.75 1.85 1.58 <-Median-> 10 Price/GP Ratio US$
Price/GP Ratio High 2.45 2.26 2.04 1.95 1.81 1.52 1.40 1.67 1.61 1.79 1.92 1.89 2.10 1.80 <-Median-> 10 Price/GP Ratio US$
Price/GP Ratio Low 1.88 1.96 1.71 1.71 1.39 1.09 1.21 1.42 1.38 1.33 1.53 1.61 1.61 1.41 <-Median-> 10 Price/GP Ratio US$
Price/GP Ratio Close 2.42 1.95 1.96 1.90 1.51 1.51 1.31 1.62 1.56 1.72 1.84 1.82 1.93 1.85 2.03 1.67 <-Median-> 10 Price/GP Ratio US$
Prem/Disc Close 142.32% 95.48% 95.82% 89.70% 50.81% 51.18% 31.39% 61.67% 55.73% 71.82% 84.45% 82.04% 92.76% 84.60% 103.27% 66.75% <-Median-> 10 Graham Price
Dec-04 Dec-05 Dec-06 Dec-07 Dec-08 Dec-09 Dec-10 Dec-11 Dec-12 Dec-13 Dec-14 Dec-15 Dec-16 Dec-17 Dec-18
pre-split 1989
pre-split 1992
pre-split 1996
pre-split 2001
Price Close $63.42 $60.10 $66.06 $66.70 $59.86 $64.41 $61.94 $65.58 $70.10 $91.59 $104.57 $102.72 $114.91 $114.91 $126.53 70.92% <-Total Growth 10 Stock Price US$
Increase 25.29% -5.23% 9.92% 0.97% -10.25% 7.60% -3.83% 5.88% 6.89% 30.66% 14.17% -1.77% 11.87% 0.00% 10.11% 5.51% <-IRR #YR-> 10 Stock Price US$
P/E 22.33 17.37 17.71 18.37 13.10 14.64 12.96 18.79 18.16 19.04 18.35 18.74 19.22 17.62 19.41 10.65% <-IRR #YR-> 5 Stock Price US$
Trailing P/E 26.43 21.16 19.09 17.88 16.49 14.09 14.08 13.72 20.09 23.73 21.74 18.02 20.97 19.22 19.41 8.29% <-IRR #YR-> 10 Price & Dividend US$
Median 10, 5 Yrs D. per yr 2.78% 3.41% % Tot Ret 33.57% 24.26% Price Inc 6.89% P/E: 18.25 18.74 14.06% <-IRR #YR-> 5 Price & Dividend US$
-$60.10 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $102.72
-$61.94 $0.00 $0.00 $0.00 $0.00 $102.72
-$60.10 $1.46 $1.62 $1.80 $1.93 $2.11 $2.25 $2.40 $2.59 $2.76 $105.67
-$61.94 $2.25 $2.40 $2.59 $2.76 $105.67
Price Med H/L $56.75 $64.78 $63.18 $64.24 $63.52 $55.78 $61.53 $62.79 $67.37 $83.05 $97.85 $98.56 $110.58 10.11% 52.16% <-Total Growth 10 Stock Price US$
Increase 5.95% 14.14% -2.46% 1.67% -1.12% -12.18% 10.30% 2.06% 7.29% 23.28% 17.82% 0.73% 12.19% 2.78% 4.29% <-IRR #YR-> 10 Stock Price US$
P/E 19.98 18.72 16.94 17.70 13.90 12.68 12.87 17.99 17.45 17.27 17.17 17.99 18.49 12.90% 9.88% <-IRR #YR-> 5 Stock Price US$
Trailing P/E 23.65 22.81 18.26 17.22 17.50 12.21 13.98 13.14 19.30 21.51 20.34 17.29 20.18 7.01% <-IRR #YR-> 10 Price & Dividend US$
P/E on Run. 5 yr Ave 26.15 25.50 21.65 20.00 17.42 14.09 14.57 15.04 15.96 19.46 21.61 21.11 21.40 13.36% <-IRR #YR-> 5 Price & Dividend US$
P/E on Run. 10 yr Ave 34.31 33.97 29.06 26.54 22.92 18.20 18.20 17.71 18.13 20.99 23.06 22.17 23.68 18.09 P/E Ratio Historical Median US$
Median 10, 5 Yrs D. per yr 2.72% 3.48% % Tot Ret 38.84% 26.03% Price Inc 7.29% P/E: 17.22 17.45
-$64.78 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $98.56
-$61.53 $0.00 $0.00 $0.00 $0.00 $98.56
-$64.78 $1.46 $1.62 $1.80 $1.93 $2.11 $2.25 $2.40 $2.59 $2.76 $101.51
-$61.53 $2.25 $2.40 $2.59 $2.76 $101.51
High Months Oct-Dec Apr Nov Nov Aug Dec Apr Jul Oct Aug Nov Jan Aug
pre-split 1989
pre-split 1992
pre-split 1996
pre-split 2001
Price High $64.25 $69.40 $68.71 $68.40 $71.70 $64.96 $66.03 $67.92 $72.52 $95.25 $109.07 $106.39 $125.40 53.30% <-Total Growth 10 Stock Price US$
Increase 8.75% 8.02% -0.99% -0.45% 4.82% -9.40% 1.65% 2.86% 6.77% 31.34% 14.51% -2.46% 17.87% 4.36% <-IRR #YR-> 10 Stock Price US$
P/E 22.62 20.06 18.42 18.84 15.69 14.76 13.81 19.46 18.79 19.80 19.14 19.41 20.97 10.01% <-IRR #YR-> 5 Stock Price US$
Trailing P/E 26.77 24.44 19.86 18.34 19.75 14.21 15.01 14.21 20.78 24.68 22.68 18.66 22.88 19.93 P/E Ratio Historical Median US$
Median 10, 5 Yrs Price Inc 6.77% P/E: 18.82 19.41 30.98 P/E Ratio Historical High US$
-$69.40 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $106.39
-$66.03 $0.00 $0.00 $0.00 $0.00 $106.39
Low Months Jan-Mar Dec Mar Jul Dec Mar Jul Mar Jun Jan Feb Aug Jan
Price Low $49.25 $60.15 $57.65 $60.07 $55.33 $46.60 $57.02 $57.66 $62.21 $70.84 $86.62 $90.73 $95.75 50.84% <-Total Growth 10 Stock Price US$
Increase 2.50% 22.13% -4.16% 4.20% -7.89% -15.78% 22.36% 1.12% 7.89% 13.87% 22.28% 4.74% 5.53% 4.20% <-IRR #YR-> 10 Stock Price US$
P/E 17.34 17.38 15.46 16.55 12.11 10.59 11.93 16.52 16.12 14.73 15.20 16.56 16.01 9.73% <-IRR #YR-> 5 Stock Price US$
Trailing P/E 20.52 21.18 16.66 16.10 15.24 10.20 12.96 12.06 17.83 18.35 18.01 15.92 17.47 16.32 P/E Ratio Historical Median US$
Median 10, 5 Yrs Price Inc 7.89% P/E: 15.33 16.12 12.86 P/E Ratio Historical Low US$
-$60.15 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $90.73
Long Term Debt $15,122 $12,857 $23,546 Debt US$
Ratio to Market Cap 0.05 0.05 0.07 0.05 <-Median-> 3 % of Market C. US$
Goodwill & Intangibles $51,176 $50,745 $49,054 $47,393 $50,813 Intangibles Goodwill US$
Ratio to Market Cap 26.27% 19.64% 16.85% 16.75% 16.05% 0.18 <-Median-> 5 % of Market C. US$
Market Cap $188,213 $187,502 $191,531 $190,879 $166,086 $177,714 $169,592 $178,640 $194,772 $258,341 $291,042 $283,010 $316,596 $316,596 $348,611 50.94% <-Total Growth 10 Market Cap US$
Diluted 3,003.5 3,012.5 2,961.0 2,910.7 2,835.6 2,789.1 2,788.8 2,775.3 2,812.6 2,877.0 2,863.9 2,112.9 2,112.9 2,112.9 Diluted Average
Change -0.15% 0.30% -1.71% -1.70% -2.58% -1.64% -0.01% -0.48% 1.34% 2.29% -0.46% -26.22% 0.00% 0.00%
Average # of Sh in M 3,003.5 3,012.5 2,961.0 2,910.7 2,835.6 2,789.1 2,751.4 2,736.0 2,753.3 2,809.2 2,815.2 2,771.8 2,771.8 2,771.8 Basic Average
Change -0.15% 0.30% -1.71% -1.70% -2.58% -1.64% -1.35% -0.56% 0.63% 2.03% 0.21% -1.54% 0.00% 0.00% Increase
Difference -1.2% 3.6% -2.1% -1.7% -2.2% -1.1% -0.5% -0.4% 0.9% 0.4% -1.1% -0.6% Difference
$17,196 <-12 mths -10.80%
# of Share in Millions 2,967.7 3,119.8 2,899.4 2,861.8 2,774.6 2,759.1 2,738.0 2,724.0 2,778.5 2,820.6 2,783.2 2,755.2 2,755.2 2,755.2 2,755.2 -1.24% <-IRR #YR-> 10 Shares
Change -0.01% 5.13% -7.07% -1.30% -3.05% -0.56% -0.76% -0.51% 2.00% 1.52% -1.33% -1.01% 0.00% 0.00% 0.00% 0.13% <-IRR #YR-> 5 Shares
CF fr Op $M $11,131 $11,877 $14,248 $15,249 $14,972 $16,571 $16,385 $14,298 $15,396 $17,414 $18,471 $19,279 $18,019 $22,482 62.32% <-Total Growth 10 Cash Flow US$
Increase 5.06% 6.70% 19.96% 7.03% -1.82% 10.68% -1.12% -12.74% 7.68% 13.11% 6.07% 4.37% -6.54% 24.77% SO, S. Iss Buy Backs US$
5 year Running Average $9,134 $10,129 $11,205 $12,620 $13,495 $14,583 $15,485 $15,495 $15,524 $16,013 $16,393 $16,972 $17,716 $19,133 67.56% <-Total Growth 10 CF 5 Yr Running US$
CFPS $3.75 $3.81 $4.91 $5.33 $5.40 $6.01 $5.98 $5.25 $5.54 $6.17 $6.64 $7.00 $6.54 $8.16 83.81% <-Total Growth 10 Cash Flow per Share US$
Increase 5.07% 1.50% 29.09% 8.43% 1.27% 11.30% -0.36% -12.29% 5.57% 11.42% 7.50% 5.44% -6.54% 24.77% 4.96% <-IRR #YR-> 10 Cash Flow US$
5 year Running Average $3.09 $3.35 $3.76 $4.27 $4.64 $5.09 $5.53 $5.59 $5.64 $5.79 $5.92 $6.12 $6.38 $6.90 3.31% <-IRR #YR-> 5 Cash Flow US$
P/CF on Med Price 15.13 17.02 12.86 12.05 11.77 9.29 10.28 11.96 12.16 13.45 14.74 14.09 16.91 6.28% <-IRR #YR-> 10 Cash Flow per Share US$
P/CF on Closing Price 16.91 15.79 13.44 12.52 11.09 10.72 10.35 12.49 12.65 14.84 15.76 14.68 17.57 3.18% <-IRR #YR-> 5 Cash Flow per Share US$
6.20% <-IRR #YR-> 10 CFPS 5 yr Running US$
Excl.Working Capital CF -$975 $912 -$982 -$1,458 $1,458 -$1,339 $870 -$1,651 $1,969 $941 $1,066 -$1,339 $0 $0 2.06% <-IRR #YR-> 5 CFPS 5 yr Running US$
CF fr Op $M WC $10,156 $12,789 $13,266 $13,791 $16,430 $15,232 $17,255 $12,647 $17,365 $18,355 $19,537 $17,940 $18,019 $22,482 40.28% <-Total Growth 10 Cash Flow less WC US$
Increase 9.56% 25.93% 3.73% 3.96% 19.14% -7.29% 13.28% -26.71% 37.31% 5.70% 6.44% -8.17% 0.44% 24.77% 3.44% <-IRR #YR-> 10 Cash Flow less WC US$
5 year Running Average $8,348 $9,591 $10,770 $11,854 $13,286 $14,302 $15,195 $15,071 $15,786 $16,171 $17,032 $17,169 $18,243 $19,267 0.78% <-IRR #YR-> 5 Cash Flow less WC US$
CFPS Excl. WC $3.42 $4.10 $4.58 $4.82 $5.92 $5.52 $6.30 $4.64 $6.25 $6.51 $7.02 $6.51 $6.54 $8.16 6.00% <-IRR #YR-> 10 CF less WC 5 Yr Run US$
Increase 9.57% 19.79% 11.62% 5.32% 22.88% -6.77% 14.15% -26.33% 34.61% 4.12% 7.87% -7.24% 0.44% 24.77% 2.47% <-IRR #YR-> 5 CF less WC 5 Yr Run US$
5 year Running Average $2.83 $3.17 $3.61 $4.01 $4.57 $4.99 $5.43 $5.44 $5.73 $5.84 $6.14 $6.19 $6.57 $6.95 4.74% <-IRR #YR-> 10 CFPS - Less WC US$
P/CF on Med Price 16.58 15.80 13.81 13.33 10.73 10.10 9.76 13.52 10.78 12.76 13.94 15.14 0.66% <-IRR #YR-> 5 CFPS - Less WC US$
P/CF on Closing Price 18.53 14.66 14.44 13.84 10.11 11.67 9.83 14.13 11.22 14.07 14.90 15.78 17.57 14.08 6.90% <-IRR #YR-> 10 CFPS 5 yr Running US$
*Operational Cash Flow per share P/CF Med 10 yr 13.05 5 yr 13.52 34.69% Diff M/C 2.65% <-IRR #YR-> 5 CFPS 5 yr Running US$
-$3.81 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $7.00 Cash Flow per Share US$
-$5.98 $0.00 $0.00 $0.00 $0.00 $7.00 Cash Flow per Share US$
-$3.35 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.12 CFPS 5 yr Running US$
-$5.53 $0.00 $0.00 $0.00 $0.00 $6.12 CFPS 5 yr Running US$
-$12,789 $0 $0 $0 $0 $0 $0 $0 $0 $0 $17,940 Cash Flow less WC US$
-$17,255 $0 $0 $0 $0 $17,940 Cash Flow less WC US$
-$9,591 $0 $0 $0 $0 $0 $0 $0 $0 $0 $17,169 CF less WC 5 Yr Run US$
-$15,195 $0 $0 $0 $0 $17,169 CF less WC 5 Yr Run US$
-$4.10 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.51 CFPS - Less WC US$
-$6.30 $0.00 $0.00 $0.00 $0.00 $6.51 CFPS - Less WC US$
-$3.17 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.19 CFPS 5 yr Running US$
-$5.43 $0.00 $0.00 $0.00 $0.00 $6.19 CFPS 5 yr Running US$
OPM 23.51% 23.51% 26.72% 24.96% 23.49% 26.77% 26.60% 21.99% 22.90% 24.42% 24.85% 27.51% 17.01% <-Total Growth 10 OPM US$
Increase -7.11% 0.01% 13.64% -6.59% -5.90% 13.99% -0.62% -17.36% 4.17% 6.62% 1.76% 10.72% Should increase or be stable. US$
Diff from Median -5.6% -5.6% 7.3% 0.2% -5.7% 7.5% 6.8% -11.7% -8.0% -1.9% -0.2% 10.5% 0.00 <-Median-> 10 OPM US$
*Operational Profit Margin (CF/Revenue) Ratio OPM 10 Yrs 24.90% 5 Yrs 24.42% should be zero, it is a check on calculations US$
Current Assets $27,320 $31,394 $22,975 $29,945 $34,377 $39,541 $47,307 $54,316 $46,116 $56,407 $59,311 $60,210 $63,319 Liquidity ratio of 1.5 and up, best US$
Current Liabilities $13,927 $12,635 $19,161 $19,837 $20,852 $21,731 $23,072 $22,811 $24,262 $25,675 $25,085 $27,747 $23,230 1.98 <-Median-> 10 Ratio US$
Liquidity 1.96 2.48 1.20 1.51 1.65 1.82 2.05 2.38 1.90 2.20 2.36 2.17 2.73 2.20 <-Median-> 5 Ratio US$
Liq. with CF aft div 2.53 3.11 1.72 2.04 2.13 2.34 2.51 2.74 2.26 2.59 2.79 2.57 3.13 2.59 <-Median-> 5 Ratio US$
Liq. CF re Inv+Div 2.16 2.29 0.84 1.56 1.77 1.73 1.87 2.28 1.91 2.16 1.87 2.01 3.13 2.01 <-Median-> 5 Ratio US$
Assets $53,317 $58,025 $70,556 $80,954 $84,912 $94,682 $102,908 $113,644 $121,347 $132,683 $131,119 $133,411 $140,369 Debt Ratio of 1.5 and up, best US$
Liabilities $21,504 $20,145 $31,238 $37,635 $42,401 $44,094 $46,329 $56,564 $56,521 $58,630 $61,367 $62,261 $67,600 2.15 <-Median-> 10 Ratio US$
Debt Ratio 2.48 2.88 2.26 2.15 2.00 2.15 2.22 2.01 2.15 2.26 2.14 2.14 2.08 2.14 <-Median-> 5 Ratio US$
Book Value $31,813 $37,880 $39,318 $43,319 $42,511 $50,588 $56,579 $57,080 $64,826 $74,053 $69,752 $71,150 $72,769 $72,769 $72,769 87.83% <-Total Growth 10 Book Value US$
pre-split 2001
Book Value per Share $10.72 $12.14 $13.56 $15.14 $15.32 $18.33 $20.66 $20.95 $23.33 $26.25 $25.06 $25.82 $26.41 $26.41 $26.41 112.69% <-Total Growth 10 Book Value per Share US$
Change 18.45% 13.27% 11.69% 11.62% 1.22% 19.67% 12.70% 1.40% 11.34% 12.53% -4.54% 3.04% 2.28% 0.00% 0.00% 17.27% P/B Ratio Current/10 Year Median US$
P/B Ratio (Median) 5.92 4.95 4.87 4.41 3.91 3.51 3.00 3.13 3.00 3.49 4.17 3.98 4.35 4.95 P/B Ratio Historical Median
P/B Ratio (Close) 5.92 4.95 4.87 4.41 3.91 3.51 3.00 3.13 3.00 3.49 4.17 3.98 4.35 4.35 4.79 7.84% <-IRR #YR-> 10 Book Value US$
Change 5.77% -16.33% -1.59% -9.55% -11.34% -10.08% -14.68% 4.41% -4.00% 16.11% 19.60% -4.67% 9.38% 0.00% 10.11% 4.56% <-IRR #YR-> 5 Book Value US$
Leverage (A/BV) 1.68 1.53 1.79 1.87 2.00 1.87 1.82 1.99 1.87 1.79 1.88 1.88 1.93 1.88 <-Average 10 A/BV US$
Debt/Equity Ratio 0.68 0.53 0.79 0.87 1.00 0.87 0.82 0.99 0.87 0.79 0.88 0.88 0.93 0.88 <-Average 10 Debt/Eq R. US$
Sharerholders Equity (Assets less liabilities) P/BV 10 yr Med 3.71 5 yr Med 3.49 17.27% Diff M/C 1.84 Historical Leverage (A/BK)
-$12.14 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $25.82
-$20.66 $0.00 $0.00 $0.00 $0.00 $25.82
$16,087 <-12 mths 24.07%
Comprehensive Income $11,357 $11,996 $8,660 $14,163 $12,861 $7,571 $10,675 $16,781 $8,461 $12,966 14.17% <-Total Growth 9 Comprehensive Income US$
Increase 5.63% -27.81% 63.55% -9.19% -41.13% 41.00% 57.20% -49.58% 53.24% 41.00% <-Median-> 5 Comprehensive Income US$
5 Yr Running Average $11,807 $11,050 $10,786 $12,410 $11,270 $11,291 1.48% <-IRR #YR-> 9 Comprehensive Income US$
ROE 28.9% 27.7% 20.4% 28.0% 22.7% 13.3% 16.5% 22.7% 12.1% 18.2% 0.16% <-IRR #YR-> 5 Comprehensive Income US$
5Yr Median 27.7% 22.7% 20.4% 22.7% 16.5% 16.5% -0.89% <-IRR #YR-> 5 5 Yr Running Average US$
% Difference from NI 2.8% 13.4% -33.1% 15.5% -3.5% -21.7% 1.5% 21.3% -48.2% -15.9% -0.89% <-IRR #YR-> 5 5 Yr Running Average US$
Median Values Diff 5, 10 yr -1.0% -15.9% 16.5% <-Median-> 5 Return on Equity US$
-$11,357 $0 $0 $0 $0 $0 $0 $0 $0 $12,966
-$12,861 $0 $0 $0 $0 $12,966
-$11,807 $0.0 $0.0 $0.0 $0.0 $11,291
-$11,807 $0.0 $0.0 $0.0 $0.0 $11,291
Return on Assets 16.0% 17.9% 15.7% 13.1% 15.2% 13.0% 13.0% 8.5% 8.7% 10.4% 12.4% 11.6% Net Income/Assets ROA US$
5Yr Median 14.9% 16.0% 16.0% 15.7% 15.7% 15.2% 13.1% 13.0% 13.0% 10.4% 10.4% 10.4% 10.4% <-Median-> 5 ROA US$
ROE 26.7% 27.5% 28.1% 24.4% 30.5% 24.2% 23.6% 16.9% 16.2% 18.7% 23.4% 21.7% Net Inc/ Shareholders' equity ROE US$
5Yr Median 26.7% 26.8% 27.5% 26.8% 27.5% 27.5% 24.4% 24.2% 23.6% 18.7% 18.7% 18.7% 18.7% <-Median-> 5 ROE US$
$15,941 <-12 mths 3.45%
Net Income $8,509 $10,411 $11,053 $10,576 $12,949 $12,266 $13,334 $9,672 $10,514 $13,831 $16,323 $15,409 $16,117 $17,417 48.01% <-Total Growth 10 Net Income US$
Increase 18.23% 22.35% 6.17% -4.32% 22.44% -5.27% 8.71% -27.46% 8.71% 31.55% 18.02% -5.60% 4.59% 8.07% EPS/CF Ratio should not be higher than 1.00 US$
5 Yr Running Average $6,585 $7,676 $8,753 $9,549 $10,700 $11,451 $12,036 $11,759 $11,747 $11,923 $12,735 $13,150 $14,439 $15,819 4.00% <-IRR #YR-> 10 Net Income US$
Operating Cash Flow $11,131 $11,877 $14,248 $15,249 $14,972 $16,571 $16,385 $14,298 $15,396 $17,414 $18,471 $19,279 2.93% <-IRR #YR-> 5 Net Income US$
Investment Cash Flow -$2,347 -$4,521 -$20,291 -$6,139 -$4,187 -$7,598 -$7,854 -$4,612 -$4,510 -$5,163 -$12,305 -$7,735 5.53% <-IRR #YR-> 10 5 Yr Running Average US$
Total Accruals -$275 $3,055 $17,096 $1,466 $2,164 $3,293 $4,803 -$14 -$372 $1,580 $10,157 $3,865 1.79% <-IRR #YR-> 5 5 Yr Running Average US$
Total Assets $53,317 $58,025 $70,556 $80,954 $84,912 $94,682 $102,908 $113,644 $121,347 $132,683 $131,119 $133,411 Balance Sheet Assets US$
Accruals Ratio -0.52% 5.26% 24.23% 1.81% 2.55% 3.48% 4.67% -0.01% -0.31% 1.19% 7.75% 2.90% 1.19% <-Median-> 5 Ratio US$
EPS/CF Ratio 0.83 0.84 0.82 0.75 0.77 0.80 0.76 0.75 0.62 0.74 0.81 0.84 0.77 <-Median-> 10 EPS/CF Ratio US$
-$10,411 $0 $0 $0 $0 $0 $0 $0 $0 $0 $15,409
-$13,334 $0 $0 $0 $0 $15,409
-$7,676 $0 $0 $0 $0 $0 $0 $0 $0 $0 $13,150
-$12,036 $0 $0 $0 $0 $13,150
Financial Cash Flow -$2,347 -$297 -$6,109 -$5,698 -$7,464 -$4,092 -$4,980 -$4,452 -$20,562 -$6,091 -$12,260 -$10,846 C F Statement Financial Cash Flow US$
Total Accruals $2,072 $3,352 $23,205 $7,164 $9,628 $7,385 $9,783 $4,438 $20,190 $7,671 $22,417 $14,711 Accruals US$
Accruals Ratio 3.89% 5.78% 32.89% 8.85% 11.34% 7.80% 9.51% 3.91% 16.64% 5.78% 17.10% 11.03% 11.03% <-Median-> 5 Ratio US$
Cash $19,355 $24,542 $14,911 $20,927 $14,523 $13,732 $18,205 Cash US$
Cash per Share $7.07 $9.01 $5.37 $7.42 $5.22 $4.98 $6.61 $5.37 <-Median-> 5 Cash per Share US$
Percentage of Stock Price 11.41% 13.74% 7.66% 8.10% 4.99% 4.85% 5.75% 7.66% <-Median-> 5 % of Stock Price US$
Notes
Mpve,ber 19, 2016. Last estimtes were for 2015, 2016 and 2017 of $70173M, $72312M and $75389M for Revenue, $6.12, $6.69 for 2015 and 2016 of Adjusted EPS,
$5.63, $5.989 and $6.52 for EPS, $6.54, $7.52 and $8.16 for CFPS, $15985M, $16117M and $17417M for Net Income.
November 22, 2015. Last estimates were for 2014, 2015 and 2016 of $74796, $75748 and $78493 for Revenue, $5.80, $6.08 and $6.64 for EPS, $6.88, $7.64 and $8.28 for CFPS and $16608M, $17424M and $19021M for Net Income.
November 25, 2014. Last estimates were for 70898M, 73921M and $77198M for revenue, $5.48, $5.84 and $6.24 for Adjusted Earnings, $3.96 for EPS for 2013, $5.55, $6.89 and $7.10 for CFPS.
November 2, 2013. Last estimates were for 2012 and 2013 and were $67,166M and $72,120M for revenue, Adjusted earnings of $5.06 and $5.47, EPS of $3.52 and $3.96.
Sep 11, 2012. Last estimates were for 2011 and 2012 of EPS $4.84 and $5.12 USD
Feb 19, 2011. I noticed that my number of shares were off and corrected them. The further back I went the closer where the share No. I had. I obvious do not know how to get No. of shares
from JNJ annual statements. The current share number times stock price is now close to market cap of a number of sites. Dec 2010 figures are from unaudited statements.
However, so far JNJ has only put out income statement.
2006. Stock is going no where, so I am selling.
AP 2005. I sometimes wonder if I did the right thing to buy this stock. Looking at reports Srandard and Poor rating it a buy as do Vickers. I will hold for now. Dividends are good.
JNJ traces its roots back 128 years, to 1886, when it was founded by three brothers: Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson, in New Brunswick, New Jersey.
Johnson & Johnson began trading publicly in 1944.
Sector
Health Care, Consumers
What should this stock accomplish?
Would I buy this company and Why.
Dividends
It is in cycle 3. Dividends are declared in the prior month. Dividends are paid in March, June, September and December.
For example, the dividend declared for shareholders of record of February 26, 2013 was paid on March 12, 2013.
Why am I following this stock.
As Canadians, we are told we should be buying US stocks for our portfolio. It is often recommended that we have at least 25% of our portfolio in US stocks. I have never followed this,
although I have tried dipping into the US market, but I have never made any money there. I bought some of this stock in June 2005 and realized a year later, in June of 2006 that it was going nowhere for
me and sold. I lost almost 17% of my investment. When I bought in 2005, all the analysts were saying that it was a good buy at that time.
How they make their money.
Johnson & Johnson is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world.
The company's worldwide business is divided into three segments: Consumer; Pharmaceutical; and Professional.
For most ratios, lower is better when looking for a good stock price. However, there are exceptions such as for yield and asset/liability ratios and here you want a higher ratios to indicate a good stock price.
Also, for the Operational Profit Margin, a higher percentage is better. With the OPM, you should only compare companies in similar industries.
Copyright 2008 Website of SPBrunner. All rights reserved.
Shares; '%, Value $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M
Date Sep 24 2012 Nov 2 2013 Nov 25 2014 Nov 22 2015 Nov 19 2016
Alex Gorsky 0.071 0.00% 0.079 0.00% 0.115 0.004% 0.178 0.006%
Chair & CEO - Shares - Amount $6.490 $8.257 $11.790 $20.489
Options - percentage 0.000 0.00% 0.147 0.01% 0.149 0.01% 0.181 0.007%
Options - amount $0.000 $15.364 $15.324 $20.771
Weldon, William C 0.410 0.01%
CEO - Shares - Amount $28.741
Caruso Dominic J 0.062 0.00% 0.089 0.00% 0.117 0.004%
CFO - Shares - Amount $6.473 $9.142 $13.443
Options - percentage 0.013 0.00% 0.000 0.00% 0.000 0.000%
Options - amount $1.319 $0.000 $0.000
Deyo, Russell C 0.140 0.01%
GC $9.814
Peterson Sandra E 0.010 0.00% 0.000 0.00% 0.036 0.001%
Officer - Shares - Amount $0.996 $0.000 $4.096
Options - percentage 0.042 0.00% 0.026 0.00% 0.061 0.002%
Options - amount $4.370 $2.626 $7.036
Goggins, Colleen A 0.110 0.00%
Officer - Shares - Amount $7.711
Options - percentage 9.530 0.34%
Options - amount $668.053
Beckerte, Mary C. 0.000 0.000%
Director - Shares - Amount $0.000
Options - percentage 0.002 0.000%
Options - amount $0.187
Coleman Mary Sue 0.014 0.00% 0.013 0.00% 0.012 0.000%
Director - Shares - Amount $1.422 $1.294 $1.373
Options - percentage 0.021 0.00% 0.023 0.00% 0.025 0.001%
Options - amount $2.182 $2.358 $2.905
Increase in O/S Shares 26.007 0.92% 55.170 1.96% 48.555 1.72% 32.302 1.16% 24.413 0.89%
due to SO $2,382 $5,053 $4,447 $3,377.820 $2,507.703
Book Value $1,649 $3,250 $3,367 $2,933.000 $2,497.000
Insider Buying -0.356 -$24.94 -$0.496 -$0.100
Insider Selling 0.345 $24.16 $32.276 $35.518
Net Insider Selling -$0.777 $5.883 $31.780 $35.418
% of Market Cap 0.00% 0.002% 0.01% 0.01%
Directors 12 13 13 10
Women 3 25% 3 23% 4 31% 2 20%
Minorities 2 17% 2 15% 2 15% 2 20%
Institutions/Holdings 2,356 67.91% 0 0.00% 2,291 65.19%
Total Shares Held 1,873.280 67.42% 0.000 0.00% 1,773.413 64.37%
Increase/Decrease 61.127 3.37% 0.000 #DIV/0! -48.518 -2.66%
Starting No. of Shares 1,812.153 0.000 1,821.932